<![CDATA[Eye Opener by ExSight Ventures]]>https://podcasters.spotify.com/pod/show/james-murray8Riverside.fm (https://riverside.com)Sat, 18 Jul 2026 08:55:38 GMTTue, 28 Apr 2026 00:47:21 GMT60James MurrayEye Opener is designed for investors, innovators, and those in/interested in the ophthalmology field.episodicJames Murrayjmurray@exsightventures.comno<![CDATA[Clear Talk Live Episode 1]]>A new discussion series hosted by ExSight Ventures. The series will focus on early stage innovation from various perspectives through discussions with key stakeholders from across the innovation spectrum; researchers to founders, to strategic partners. And tonight we'll dive into the world of early stage of ophthalmic innovation from our perspective, as a venture capital firm dedicated to investing in the space and bringing transformative technologies to patients and clinicians.

]]>https://podcasters.spotify.com/pod/show/james-murray8/episodes/Clear-Talk-Live-Episode-1-e38osjhe3c5a0d9-b332-47f8-88cf-aee597a3c35fFri, 26 Sep 2025 21:21:23 GMT<p>A new discussion series hosted by ExSight Ventures. The series will focus on early stage innovation from various perspectives through discussions with key stakeholders from across the innovation spectrum; researchers to founders, to strategic partners. And tonight we'll dive into the world of early stage of ophthalmic innovation from our perspective, as a venture capital firm dedicated to investing in the space and bringing transformative technologies to patients and clinicians. </p> no00:56:1111Clear Talk Live Episode 1full<![CDATA[Inside ONL Therapeutics: Teamwork, Trust, and the Road to GALAXY]]>In this episode of The Eye Opener, we spotlight a major milestone for ONL Therapeutics, an ExSight Ventures portfolio company since 2018, as the company announced it randomized its first patient in the Phase 2 GALAXY trial.

Join ONL CEO David Esposito, COO Connie Chang, and ExSight Ventures Managing Partner James Murray as they explore the power of teamwork and leadership in biotech, and the road to bringing xelafaslatide (formerly ONL1204) into the clinic for patients suffering from geographic atrophy (GA) due to dry age-related macular degeneration (AMD).

 Topics covered:

  • How collaboration in the C-suite is an essential component of any life science and biopharma startup. 

  • Lessons from advancing a novel therapy to human trials

  • The importance of adaptability and communication in ONL's journey

 Listen now for insights at the intersection of ophthalmology, biotech innovation, and venture capital — and discover how teamwork drives ONL's pursuit of breakthroughs that could preserve sight for millions.


]]>https://podcasters.spotify.com/pod/show/james-murray8/episodes/Inside-ONL-Therapeutics-Teamwork--Trust--and-the-Road-to-GALAXY-e3aam459ef4df5a-eafb-47c8-964f-4ec390149fb1Fri, 31 Oct 2025 16:49:56 GMT<p>In this episode of <strong>The Eye Opener</strong>, we spotlight a major milestone for <strong>ONL Therapeutics</strong>, an <strong>ExSight Ventures portfolio company since 2018</strong>, as the company announced it <strong>randomized its first patient in the Phase 2 GALAXY trial</strong>.</p><p>Join <strong>ONL CEO David Esposito</strong>, <strong>COO Connie Chang</strong>, and <strong>ExSight Ventures Managing Partner James Murray</strong> as they explore the <strong>power of teamwork and leadership in biotech</strong>, and the road to bringing <strong>xelafaslatide (formerly ONL1204)</strong> into the clinic for patients suffering from <strong>geographic atrophy (GA)</strong> due to <strong>dry age-related macular degeneration (AMD)</strong>.</p><p> Topics covered:</p><ul><li><p>How collaboration in the C-suite is an essential component of any life science and biopharma startup. </p></li><li><p>Lessons from advancing a novel therapy to human trials</p></li><li><p>The importance of adaptability and communication in ONL's journey</p></li></ul><p> <strong>Listen now</strong> for insights at the intersection of <strong>ophthalmology, biotech innovation, and venture capital</strong> — and discover how teamwork drives ONL's pursuit of breakthroughs that could preserve sight for millions.</p><p><br /></p> no00:47:3912Inside ONL Therapeutics: Teamwork, Trust, and the Road to GALAXYfull